Add
DRTX to Portfolio
Set Alert
Email to a
Friend
| |||
|
|
Quotes & Info
|
| DRTX > SEC Filings for DRTX > Form 8-K on 8-Mar-2013 | All Recent SEC Filings |
8-Mar-2013
Results of Operations and Financial Condition, Financial Statements and
On March 8, 2013, Durata Therapeutics, Inc. (the "Company") announced its financial results for the year ended December 31, 2012. The full text of the press release issued in connection with the announcement is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.
The information in this Current Report on Form 8-K, including Exhibit 99.1 attached hereto, is furnished to comply with Item 2.02 of Form 8-K, and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.
(d) Exhibits.
99.1 Press Release of Durata Therapeutics, Inc., dated March 8, 2013, entitled "Durata Therapeutics, Inc. Reports Full-Year 2012 Financial Results".
|
|